EMEA-001501-PIP05-20
Key facts
| Invented name |
Dupixent
|
| Active substance |
dupilumab
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/0304/2020
|
| PIP number |
EMEA-001501-PIP05-20
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of bullous pemphigoid
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Regeneron Ireland DAC
Tel. +1 9148 475385 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|